The NYSE Welcomes vVARDIS as a Publicly Listed Company
The NYSE welcomed Swiss dental technology company vVARDIS (NYSE: VVVV) as a publicly listed company. vVARDIS markets Curodont Repair Fluoride Plus, a peptide-based, drill-free treatment for early tooth decay that has treated more than 2.5 million teeth and is available in over 20% of U.S. dental practices.
Key figures
- Teeth treated
- 2.5 million
- Us dental practice penetration
- more than 20%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.